Cheapest GLP-1 Online: How to Compare Prices Across

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult your physician or a qualified healthcare provider regarding any medical condition or treatment.

Key Takeaways

  • Legitimate online GLP-1 monthly prices range roughly from $25 with strong insurance coverage to $1,500 cash for branded Wegovy or Zepbound; compounded options through telehealth typically fall in the $200 to $400 range.
  • Eli Lilly Direct sells brand Zepbound vials directly online at a roughly 50 percent discount versus pen pricing, starting around $349 to $499 monthly for self-pay patients.
  • Compounded semaglutide and tirzepatide are now narrowly restricted after the FDA declared the shortages resolved, which has tightened supply and ended some of the cheapest historical options.
  • Any online source under about $100 a month is almost certainly counterfeit, illegally imported, or "research peptides" — both unsafe and federally illegal for human use.
  • Compare total program cost (clinician visit, follow-up, shipping, supplies, glucose monitoring) rather than headline drug price; some "cheap" platforms charge added fees that match higher-priced competitors.

The cheapest legitimate online GLP-1 prescriptions in 2026 fall in three tiers: branded Wegovy or Zepbound through insurance with copays as low as $25; Eli Lilly Direct self-pay vials of Zepbound at $349 to $499; and compounded semaglutide or tirzepatide through telehealth at roughly $200 to $400. Anything advertised under $100 monthly is almost always counterfeit, illegally imported, or non-compliant with FDA rules.

Online GLP-1 Price Tiers

Tier Typical Monthly Cost Source Type
Insurance with full coverage $0 to $25 Brand Wegovy / Zepbound
Insurance with manufacturer copay card $25 to $200 Brand
Eli Lilly Direct self-pay $349 to $499 (low-dose Zepbound vials) Manufacturer direct
Compounded telehealth $199 to $400 503A / 503B compounding pharmacy
Cash brand pens $1,289 to $1,499 Retail pharmacy
Below $100 (advertised) Highly suspicious Avoid

Eli Lilly Direct: Cheapest Brand Option

Eli Lilly Direct launched in 2024 as the manufacturer’s direct-to-patient pharmacy. Self-pay patients can buy Zepbound vials at lower prices than pens. The 2.5 mg and 5 mg vials run roughly $349 and $499 monthly respectively, although these prices change. Vials require manual reconstitution and a separate syringe — slightly less convenient than the auto-injector pen, but a substantial cost savings for cash payers. Read more on accessing Zepbound directly in our guide to treatment options.

Compounded GLP-1 Online: The Tightening Market

From 2022 to 2025, the FDA listed semaglutide and tirzepatide on its drug shortage list. This legally enabled 503A and 503B compounding pharmacies to make and dispense compounded versions, often at substantial discounts — Hims, Henry Meds, Mochi, Willow, Eden, Found, and others built telehealth programs around this access. In 2025 the FDA declared the shortages resolved, which reset the legal landscape:

  • Compounded products now require a documented medical reason (allergy to inactive ingredient, dose form not commercially available, etc.)
  • Several state pharmacy boards have issued cease-and-desist letters
  • Pricing has shifted upward as fewer pharmacies remain in the market
  • Some platforms have pivoted to selling brand Wegovy or Zepbound

Insurance: Where the Real Savings Are

If your plan covers obesity medication, your copay is typically the cheapest path. Steps to maximize coverage:

  • Confirm coverage with your insurer for the specific drug (Wegovy, Zepbound, Ozempic, Mounjaro)
  • Have your prescriber submit a prior authorization with BMI documentation, comorbidities, and prior weight-loss attempts
  • Apply for the manufacturer copay card (Novo Nordisk Wegovy, Eli Lilly Zepbound)
  • Ask about mail-order 90-day supplies for additional savings
  • Compare GoodRx, SingleCare, and RxSaver coupons at multiple pharmacies

How to Compare Online Telehealth Platform Prices

Headline prices can be misleading. Compare total cost over a 90-day period, including:

  • Initial visit fee (some platforms charge $0, others $99 to $199)
  • Monthly drug cost
  • Refill or follow-up fees
  • Shipping (often free, sometimes $20+ per shipment)
  • Lab work if required
  • Cancellation flexibility (some require commitment with refund penalties)

Red Flags for Counterfeit or Illegal Online GLP-1

  • Prices under $100 a month for compounded; under $300 for brand
  • No prescription required
  • Ships from outside the United States
  • Pays in cryptocurrency or wire transfer only
  • “Research peptides” or “for research only” disclaimers
  • Pharmacy is not state-licensed
  • No live clinician contact for side effects
  • Reviews mention unmarked vials, missing labels, or inconsistent appearance

The FDA has documented hospitalizations and deaths from counterfeit GLP-1 products. Cheap is not worth that risk.

Reputable Online GLP-1 Platforms in 2026

Platform Typical Monthly Cost Coverage
Eli Lilly Direct (Zepbound vials) $349 to $549 Self-pay
Hims and Hers $249 to $399 (compounded where legal) Self-pay
Ro Body $135 to $399 plus drug cost Insurance and self-pay
Sequence (WW Clinic) $99 plus drug cost Insurance preferred
Found $99 plus drug cost Insurance and self-pay
Noom Med $129 plus drug cost Insurance encouraged
Mochi Health $249 plus drug cost Self-pay

Pricing changes frequently — verify on each platform before signing up. Some require an initial 1- to 3-month commitment.

What “Cheap” Should Not Mean

  • Skipping clinical follow-up for side effects
  • No glucose check if you have diabetes
  • Mystery active ingredient in compounded products
  • Pharmacy you cannot verify by name with your state board
  • Generic dosing schedule that ignores your medical history

For more on the GLP-1 landscape, see our guides to treatment options and prediabetes basics.

The Bottom Line

The cheapest legitimate online GLP-1 in 2026 starts at insurance copay (as low as $25), then Eli Lilly Direct Zepbound vials at $349 to $499, then compounded semaglutide or tirzepatide through licensed telehealth at $199 to $400. Anything below $100 monthly is almost always counterfeit. Use insurance first, manufacturer direct second, and compounded third — and verify the pharmacy is state-licensed in every case. The cost difference between a legitimate cheap source and a dangerous one is often less than $100 a month, and the safety difference is enormous.

Frequently Asked Questions

What is the absolute cheapest legitimate online GLP-1?

With insurance that covers obesity medication, branded Wegovy or Zepbound copays can run as low as $25 a month. Without insurance, Eli Lilly Direct vials of Zepbound at the lower doses are typically the cheapest brand option at about $349 to $499 monthly. Compounded semaglutide, where still legally dispensed, ranges $200 to $400 monthly.

Why are some online GLP-1 ads showing prices like $99 a month?

That price point usually requires a 12-month prepayment, may be only the first month, or may be a non-FDA-compliant compounded product. Read the fine print — many "$99" offers escalate to $300 to $500 after the first month or are time-limited promotional pricing tied to long-term commitments.

Is cheaper compounded GLP-1 as effective as brand?

When a compounding pharmacy uses real semaglutide or tirzepatide active ingredient at the prescribed dose, clinical effects should be similar to brand. The risks come from quality variability, potency inconsistency, and the legal restrictions imposed after the FDA-declared shortage resolution — many former low-cost compounded sources are no longer legally available.

Does my insurance cover online GLP-1 prescriptions?

Coverage depends on your plan, the GLP-1 indication (diabetes versus weight loss), and prior authorization documentation. Most major commercial plans cover Ozempic and Mounjaro for type 2 diabetes; coverage for Wegovy and Zepbound for obesity is improving but still limited. Telehealth platforms often help with prior authorization paperwork.

Sources

  1. U.S. Food and Drug Administration. FDA's Concerns with Unapproved GLP-1 Drugs Used for Weight Loss.
  2. Eli Lilly. LillyDirect platform pricing.
  3. Novo Nordisk. Wegovy and Ozempic Prescribing Information.
  4. American Diabetes Association. Standards of Care in Diabetes 2024.